Document is current
Any future updates will be listed below
-
Authors
Roldgaard, Marcus
Benfield, Thomas
Tingsgård, Sandra
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 15 August 2023
Accepted: 12 February 2024
First Online: 23 February 2024
Declarations
:
: The study was approved by the Danish Data Protection Agency (reference HVH-2014–018, 02767) and the informed consent was waived by the Centre for Regional Development (reference R-22024473). The study was waived an exemption by the Regional Ethics Committee of the Capital Region of Denmark according to Danish legislation (ExternalRef removed).
: Not applicable.
: MR and ST have no competing interests to declare. TB reports grants from Novo Nordisk Foundation, Lundbeck Foundation, Simonsen Foundation, GSK, Pfizer, Gilead, Kai Hansen Foundation and Erik and Susanna Olesen’s Charitable Fund; personal fees from GSK, Pfizer, Boehringer Ingelheim, Gilead, MSD, Pentabase ApS, Becton Dickinson, Janssen and Astra Zeneca; outside the submitted work.
